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The somatostatin (SS) gene is transcriptionally regulated via the cyclic AMP (cAMP) response element (CRE), located in the proximal promoter (-41 to -48 bp). We have previously reported that glucocorticoids induce dose-dependent cell-specific alterations in the steady-state SS mRNA level. Here we have investigated direct transcriptional control of the SS gene by glucocorticoids. We have examined transcriptional interaction between glucocorticoids and the cAMP signalling pathway and mapped the 5' upstream 
INTRODUCTION
Somatostatin (SS) synthesis and gene expression is modulated by a number of prominent agents and mediators such as cyclic AMP (cAMP), oestrogens, testosterone, interleukin-1, insulin, growth hormone and N-methyl-D-aspartate receptor agonists [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . In mammals, synthesis of SS is directed by a single gene which contains two known regulatory elements in its proximal promoter region: a variant of the TATA box 26 bp upstream from the start of transcription, and an octameric enhancer sequence, the cAMP response element (CRE), located further upstream between nucleotides -48 and -41 [3, 12, 13] . In addition, a SS gene upstream enhancer element (SMS-UE) has recently been identified in the more distal promoter between nucleotides -113 and -83 which confers islet D-cell-specific gene expression [14, 15] . The promoter region does not contain canonical steroid or thyroid hormone response elements. Activation of the adenylate cyclase/cAMP pathway plays an important role in stimulating both secretion and gene transcription of SS [3] [4] [5] [6] . cAMP activates transcription of SS and other cellular genes through the CRE, which binds the nuclear protein CREB (CRE binding protein); the transcriptional efficacy of CREB is regulated through phosphorylation by the cAMP-dependent protein kinase A [4, 5] . Several other transcriptional factors related to CREB and capable of interacting with the CRE have also been identified, e.g. ATF-1, CRE-BPI/ATF-2, CREM, ATF-a, and so on [14] . The SMS-UE region represents a tripartite cis regulatory unit which is activated by a protein complex consisting of CREB and islet-cell-specific and a-CAAT binding factor-like transcription factors, and which is in turn synergistically coupled to the CRE located in the proximal promoter [15] [16] [17] . It is not known whether agents such as gonadal steroids, interleukin-1, insulin, growth hormone and N-methyl-Daspartate receptor agonists, which modulate SS mRNA levels, act transcriptionally, and if so, what the intracellular signalling mechanism is.
We have previously demonstrated that dexamethasone (DEX) induces tissue-specific time-and dose-dependent alterations in SS peptide production and mRNA accumulation in normal SSproducing tissues in vivo and in vitro [18] . In addition, DEX produced biphasic patterns of change in SS secretion and steadystate mRNA levels in a rat SS-producing islet tumour cell line (1027B2), with dose-dependent stimulatory and inhibitory components [18] . This suggests a complex molecular mechanism of glucocorticoid action on the SS gene, involving regulation at various levels. In the present study we [22] . Under these conditions, the assay was linear for up to 8 h and with up to 300 ,tg of extract. Routinely, 100 ,ug of cell lysate protein was incubated for 3.5 h at 37 'C. The reaction mixture was then extracted by ethyl acetate and subjected to t.l.c. followed by autoradiography. CAT activity was quantified by liquid scintillation counting of excised bands containing either the acetylated or non-acetylated forms of [14C]chloramphenicol, and was expressed as a percentage of ['4C]chloramphenicol converted to the acetylated forms. All experiments were repeated at least three times.
The plasmid pCH1 10 (Pharmacia) was routinely co-transfected with various CAT constructs and used as an internal control for monitoring transfecting efficiency [24] . It expresses constitutively the lacZ (/J-galactosidase) gene driven by the Simian virus 40 early promoter. Treatment with test agents did not produce any significant variation in fl-galactosidase activity in any experiment.
Plasmid constructions
The metallothionein-CREB (MT-CREB) expression vector has been described previously [25] . CREB expression was induced by exposure of MT-CREB-transfected cells to ZnSO4 (90,uM). The chimaeric gene constructs pSS-750CAT and pSS-71CAT (containing SS gene sequences from positions -750 to + 55 bp and -71 to + 55 bp respectively ligated to the bacterial reporter gene encoding CAT) [3] were obtained from M. R. Montminy (Salk Institute, La Jolla, CA, U.S.A.). pSS-250CAT was generated by inserting a Sall fragment (-250 to + 55 bp) of the -750 SS promoter into a pUC19-derived pCAT-Basic vector (Promega). A CRE substitution mutation in the -250 bp promoter (A-CRE pSS-250CAT) was generated by replacing the octameric CRE (TGACGTCA) with a non-related sequence of equal size (GCGTAGTC) by a two-step PCR procedure for gene splicing by overlap extension [26] . Oligonucleotide primers (38-mer) were designed with the mutant sequences flanked by 15 nucleotides of wild-type sequence at either side. A -250 to + 55 bp SS promoter fragment with the CRE substitution mutation was amplified by using as template the SS -250 to + 55 bp construct in the Bluescript plasmid (Stratagene). The mutant fragment was inserted into pCAT-Basic. All constructs and insert orientations were confirmed by restriction mapping and/or sequence analysis using the method of Sanger et al. [27] .
Gel shift assay Nuclear extracts were prepared from PC 12 cells as described [28] and dialysed overnight at 4 'C against 20 mM Hepes (pH 7.9 at 4°C), 20% glycerol, 100 initially in PC12 cells. DEX induced a significant dose-dependent increase in CAT activity from 10 nm to 0.1 ,uM, with a maximal 2.2-fold induction at I 4uM ( Figure 1 ). To test the specificity of DEX action, the ability of other steroid and thyroid hormones to alter SS gene transcription was determined (Table 1) . In contrast to DEX, oestradiol, testerone, tri-iodothyronine and retinoic acid at doses between 1 nM to 1 #M had no effect on pSS-750CAT expression in PC12 cells. Likewise, phorbol esters were without effect, whereas cAMP and forskolin induced a 4-5-fold stimulation of SS-CAT expression ( Table 1) . induced a 4-5-fold stimulation of SS promoter activity ( Figure 3 ; Table 1 ). 
Mutation of the CRE abolishes the DEX effect on SS gene transcripffon
To test the effect of mutation of the CRE on DEX-induced SS gene transcription, PC12 cells were transfected with A-CRE pSS-250CAT. Replacement of the CRE by a non-related sequence reduced basal CAT activity (% conversion of chloramphenicol into acetylated forms) from 1.42+0.280% to 0.52+0.030%
(P < 0.01). As expected, the mutation abolished the stimulatory effect of forskolin but additionally blocked DEX-induced stimulation, as well as the combined potentiation of CAT activity by forskolin and DEX (Figure 4) In a reciprocal experiment, the effect of overexpressed CREB on DEX-induced SS gene transcription was investigated. Cotransfection of PC12 cells with MT-CREB and pSS-750CAT had no effect on control CAT expression and did not enhance DEX-, forskolin-or combined forskolin and DEX-induced stimulation of CAT activity in these cells ( Figure 5 ). [14] , and led to an additive response between the two regulatory elements. Transcriptional control by steroid and thyroid hormones is mediated by a family of nuclear receptors that are activated by ligands and bind to cis regulatory elements in specific target genes [31, 32] . Previous studies have provided increasing evidence for functional interactions between the nuclear receptors and other transcription factors not involving a natural promoter [33] [34] [35] [36] [37] [38] . This is particularly the case with glucocorticoid-inducible genes, which frequently show GREs contiguous with DNA regulatory sequences for other transcription factors in the promoter region. These include binding sites for SPI, NFl, CACCC and CCAAT box binding proteins [33, 34] , CREB [35, 38] and AP-1 factors [36, 37] , or a second GRE [34] . An interaction between the glucocorticoid receptor and these accessory factors can lead to either enhancement or repression of gene transcription. Synergism between the glucocorticoid receptor and other transcription factors was first reported for NFl, SPl and CACCC binding proteins in genes encoding tyrosine aminotransferase and rat tryptophan oxygenase [33, 34] . Functional cooperativity in these instances was shown to be critically dependent on the spacing between the regulatory elements but not their orientation, and is mediated by protein-protein interaction rather than co-operative DNA binding [33, 34] . These studies additionally revealed that a single copy consensus GRE sequence isolated at a distance from the transcription start site was insufficient for gene induction, but the sequence became active when a second regulatory element including a second GRE was positioned nearby [34] . This suggests a basic model of glucocorticoidinduced transcriptional activation requiring multiple GREs or a combination of a GRE with other factor-binding sites for constitution of a hormone-inducible enhancer. More recently, the glucocorticoid receptor has been shown to repress gene expression by functional interference with several different transcriptional activators [35] [36] [37] [38] . For instance, repression of the human chorionic gonadotrophin a-subunit and pro-opiomelanocortin genes appears to be mediated by competitive binding of the glucocorticoid receptor to DNA regulatory sequences termed negative GREs, thereby displacing transcriptional activators such as CREB in the case of the a-subunit gene [35] and the CAAT box binding factor in the case of the pro-opiomelanocortin gene [38] . For other genes such as those for osteocalcin, proliferin and collagenase, glucocorticoids repress an AP-l site by a different mechanism involving a direct protein-protein interaction between c-jun and the glucocorticoid receptor leading to a mutual inhibition of their DNA binding activities [36, 37] .
Dependence ofglucocorticoid receptor-mediated enhancement of SS gene transcription on CRE/CREB activation was shown here by two lines of evidence. First, the protein kinase-A deficient mutant cell line A126-1B2, which is incapable of inducing cAMPmediated gene transcription due to an inability to phosphorylate and thereby transactivate CREB, was also unresponsive to glucocorticoid induction. Secondly, replacement of the canonical CRE in the SS gene upstream region with an inert sequence abolished both cAMP and glucocorticoid responsiveness. Failure of DEX to induce the -71 bp SS promoter suggests that the glucocorticoid receptor does not interact directly with the CRE/CREB complex. Since the -250 bp promoter showed full glucocorticoid responsiveness, our findings imply a glucocorticoid-sensitive region in the -250 to -71 sequence of the SS promoter. Gel electrophoretic mobility shift assays confirmed that the -250 to -71 bp region of the [9] . A survey of the SS gene promoter for these accessory factor binding sites shows two contiguous putative retinoic acid response element (-373 to -366 bp) and insulinresponsive sequence (-330 to -321 bp) motifs considerably further upstream from the potential glucocorticoid receptor responsive site. Despite these differences, there are sufficient similarities to suggest that the PEPCK gene could serve as a useful model for further studies to determine the precise nature of the transcriptional interaction between the glucocorticoid receptor, the CRE, and perhaps the retinoic acid receptor and insulin-sensitive transcription factors in the SS gene.
Since glucocorticoids act on numerous target genes, an interaction between glucocorticoids and the cAMP pathway could also occur at points more proximal to the gene through induction of one or more components of the cAMP signalling pathway. For instance, glucocorticoids have been reported to activate adenylate cyclase in GH3 cells [44] and could conceivably enhance cAMP-dependent gene transcription via this mechanism. Such an action, however, cannot explain the ability of glucocorticoids to potentiate the effects of high concentrations of exogenous cAMP or forskolin found in the present study. Moreover, the results of the -71 bp construct argue against this possibility. It is not known whether glucocorticoids regulate the expression of protein kinase A, although glucocorticoids stimulate CREB expression in rat C6 glioma cells [45] . Induction of either of these two molecules could represent an indirect mechanism for glucocorticoid stimulation of SS gene transcription, but cannot account for the additive effect between the activated glucocorticoid receptor and the cAMP pathway. Our results with CREB co-transfection of PC12 cells suggest that overexpression of this molecule alone is insufficient for activation of SS gene transcription. This is probably due to an abundance of endogenous CREB and related factors in these cells [14, 17, 46] , as well as the requirement not just for CREB molecules, but for phosphorylated CREB, for transcriptional activation [5, 46] . The concentration of DEX at which significant induction of SS-CAT activity occurred (10 nM) falls within the physiological range, especially if allowance is made for differences in the responses of transfected and endogenous SS genes. Since cAMP is the predominant regulator of SS gene transcription, and since glucocorticoids and cAMP influence many of the same physiological processes, a co-operative relationship between the two pathways is clearly functionally relevant. Transcriptional activity of the SS gene, however, can explain only part of glucocorticoid action on steady-state SS mRNA levels that we found in rat tissues, i.e. the stimulatory component [18] . The additional, more potent, effect of glucocorticoids resulting in inhibition of SS mRNA accumulation must therefore be mediated through a post-transcriptional mechanism [18, 47] . Studies of the effects of glucocorticoids on SS mRNA stability are necessary to investigate this question further.
In conclusion, we have demonstrated positive transcriptional control of the SS gene by glucocorticoids. Glucocorticoidinduced transactivation shows dependence on protein kinase A activity, and may be mediated via interactions between the glucocorticoid receptor and CREB. DNA sequences upstream from the CRE between -250 and -71 bp in the SS promoter appear necessary for the glucocorticoid effect.
